Floatz logo

Prasterone

Anal Carcinoma

Ohio State University Comprehensive Cancer CenterPhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

45 Active assets in the Anal Carcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Federation Francophone de Cancerologie Digestive
Phase 3BB
Carboplatin
Dustin Deming
Phase 3BB
Irinotecan
University of Cincinnati
Phase 3BB
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Federation Francophone de Cancerologie Digestive
Phase 3BB

View all 50 →

Same molecule, other indications

Prasterone is also rated in:

postmenopausal atrophic vaginitisDormant
BB
Indicative ·
66 / 100
View asset →
systemic lupus erythematosusDormant
BB
Indicative ·
66 / 100
View asset →
breast cancerDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →